+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

FDA Inspections: What to Expect, How to Prepare & Avoid 483 Observations (ONLINE EVENT: May 13-14, 2026)

  • Training

  • 2 Days
  • May 13th 12:00 - May 14th 17:00 EST
  • World Compliance Seminar
  • ID: 6057014
UP TO OFF until Jul 28th 2026

Course Format

  • Online, Live Virtual
  • Real Inspection Examples & Case Studies
  • Mock FDA Inspection Exercises
  • Practical Preparation Strategies
  • Interactive Q&A & Compliance Best Practices
  • 10 hours of Continuing Education Certificate of Completion
FDA inspections are a critical part of ensuring compliance with regulatory requirements and are a key determinant of product approval and market access.

During inspections, investigators evaluate your quality systems, documentation, data integrity, and overall compliance with cGMP requirements.

This training provides a practical, real-world approach to preparing for and managing FDA inspections - helping you avoid common mistakes and respond effectively during audits.

By attending this training, you will be able to:

  • Understand how FDA inspections are conducted and what inspectors look for
  • Prepare your facility, documentation, and team for inspections
  • Handle investigator questions and interactions confidently
  • Avoid common mistakes that lead to 483 observations
  • Respond effectively to inspection findings and implement CAPA

Why this training is important:

  • FDA inspections assess compliance with cGMP and regulatory standards
  • Inspection findings can result in 483 observations, warning letters, or delays
  • Many companies struggle with inspection readiness and response strategies
  • What you will be prepared for:
  • Pre-approval inspections
  • Routine GMP inspections
  • For-cause inspections
  • Handling FDA investigator questions
This course equips professionals with the knowledge to successfully prepare for, manage, and respond to FDA inspections, ensuring compliance and regulatory success.

Course Content

Day 1
  • Introductions and Background
  • FDA’s Inspectional Authority and History
  • FDA Inspection Program Overview
  • Key factors for a successful FDA inspection
  • Quality System Readiness
  • Organization Readiness
  • Manage Inspection Outcomes
  • Information and Documentation
  • How a firm should prepare for an FDA inspection?
  • Ways to train employees in view of the inspection
  • How to ensure that required documentation is in place
  • How to interact with the investigator-DO's and DON'T's
  • What companies should do when the inspection ends
  • How to reply to 483's and warning letters
  • Legal implications of non-compliance
  • Why inspections are conducted and by what statutory authority
  • The emphasis on systems-based inspections...and the IOM and other crucial FDA reference documents
  • What is subject to FDA purview and what's off-limits
  • Understand and apply the do's and don'ts and comprehend that preparation is the key to success
  • What are the prohibited "Acts" and the enforcement categories that you need to deal with?
  • What you need to know and do to prepare for, during and even after the inspection...and why your inspection response team is key
  • The company's Inspection Plan (SOP) can make or break the inspection depending on how to use it and training your personnel
  • How to respond to findings and facilitating the documentation and remediation process...and reaching final closure
  • Define clear responsibilities, roles and goals for personnel involved in FDA inspections and SOP development
  • Exit Interview
  • FDA interviewing employees and personnel
Day 2
  • Maintain, or return to, regulatory compliance and minimize downtime
  • Establish a risk management plan in place to proactively manage compliance, including a crisis-management plan
  • Set post-inspection deadlines and working closely with FDA’s regulatory partners
  • Compliance remediation is the process of recognizing problems, creating a plan to correct and prevent them from occurring in the future, and executing to that plan to helps with your GxP Compliance Strategy.
  • Guidance on how to request and conduct PDUFA meetings and expectations for Sponsor-FDA Meetings
  • Guidance outlining clear recommendations for sponsors and for FDA staff and managers as well for Pre-Submission meetings as expected timeframes for scheduling meetings
  • Mechanics of requesting any FDA meeting and what you need to know to be successful with communication style, approach and tactics
  • Prioritize follow-up on warning letters and other enforcement actions
  • Develop and implement a formal warning letter “close-out” process
  • Untitled Letter and the Warning Letters
  • Recent Trends and Enforcement Actions for 2017
  • Mock Inspections and Mock Audits and why role playing is important
Recap of Day 1 and Day 2
Exercise on Day 2
  • Interactive Discussions
  • Review Regulatory and Compliance Documentation
  • Recent Enforcement Actions for 2017 and Emerging FDA Trends
  • Classroom Project: Prepare for and Host an FDA Mock Inspection and Prepare Effective Company Response to FDA 483 and/or Warning Letter
Debrief/Adjourn/Wrap-Up

Agenda

Day 1: FDA Inspection Readiness & Compliance Fundamentals ( 5hrs)

Session 1: Introduction & Regulatory Foundation
  • Introductions and participant background
  • Overview of FDA’s inspectional authority and history
  • Why FDA inspections are conducted and statutory basis
  • Scope of FDA jurisdiction: what is covered vs. off-limits
Session 2: FDA Inspection Framework
  • FDA inspection program overview
  • Systems-based inspection approach
  • Key FDA reference documents (IOM and related guidance)
  • Enforcement categories and prohibited acts
Session 3: Inspection Readiness Strategy
  • Key factors for a successful FDA inspection
  • Building Quality System Readiness
  • Organizational readiness and inspection planning (SOPs)
  • Defining roles, responsibilities, and inspection response teams
Session 4: Documentation & Compliance Preparation
  • Ensuring required documentation is complete and inspection-ready
  • Information management during inspections
  • How to prepare your facility for an FDA inspection
  • Training employees for inspection readiness
Session 5: Managing the Inspection Process
  • Interacting with FDA investigators: Do’s and Don’ts
  • Handling FDA interviews with employees and personnel
  • Managing real-time inspection scenarios
Session 6: Post-Inspection Activities & Compliance
  • What to do when the inspection ends
  • Exit interview best practices
  • Responding to Form 483 observations and warning letters
  • Documentation, remediation, and achieving closure
  • Legal implications of non-compliance
Day 2: Post-Inspection Compliance, FDA Interactions & Practical Application (5hrs)

Session 1: Compliance Recovery & Risk Management
  • Strategies to maintain or return to regulatory compliance
  • Minimizing operational downtime after inspection findings
  • Establishing a proactive risk management plan
  • Building an effective crisis management strategy
Session 2: Compliance Remediation & GxP Strategy
  • Understanding the compliance remediation lifecycle
  • Identifying issues, root cause analysis, and corrective actions
  • Preventive strategies to avoid recurrence
  • Strengthening your overall GxP compliance framework
Session 3: FDA Meetings & Regulatory Communication
  • Overview of PDUFA meetings and Sponsor-FDA interactions
  • How to request and prepare for FDA meetings
  • Pre-submission meeting guidance and expected timelines
  • Best practices for effective communication with FDA
  • Key tactics for successful regulatory engagement
Session 4: Managing Enforcement Actions
  • Understanding Untitled Letters vs. Warning Letters
  • Prioritizing follow-up on enforcement actions
  • Developing a structured Warning Letter close-out process
  • Ensuring timely and effective regulatory responses
Session 5: Trends, Insights & Industry Learnings
  • Review of recent FDA enforcement trends and observations
  • Key compliance risks and emerging regulatory focus areas
  • Lessons learned from past inspection outcomes
Session 6: Mock Inspections & Practical Application
  • Importance of mock inspections and audits
  • Role-playing FDA inspection scenarios
  • Preparing teams for real inspection environments
  • Conducting internal audits to assess readiness

Course Provider

  • Kelly Thomas
  • Kelly Thomas,